首页 | 本学科首页   官方微博 | 高级检索  
检索        

非何杰金氏淋巴瘤成都分类方案的临床价值
引用本文:张尚福,谢青.非何杰金氏淋巴瘤成都分类方案的临床价值[J].华西医科大学学报,1991,22(3):307-310.
作者姓名:张尚福  谢青
摘    要:

关 键 词:淋巴瘤  非何杰金氏  成都分类方案

Clinical value of the Chengdu classification of non-Hodgkin's lymphomas]
S Zhang,S Xu,G Li,Z Su,W Liu,Q Xie,J Zhang,Z Zhang,Y Qian,J Shen.Clinical value of the Chengdu classification of non-Hodgkin''s lymphomas][J].Journal of West China University of Medical Sciences,1991,22(3):307-310.
Authors:S Zhang  S Xu  G Li  Z Su  W Liu  Q Xie  J Zhang  Z Zhang  Y Qian  J Shen
Institution:Department of Pathology, Chongqing University of Medical Sciences.
Abstract:Two hundred forty-nine cases of non-Hodgkin's lymphomas (NHL) were reviewed by using the working classification of NHL (Chengdu, 1985). The results showed that the patients of 249 cases of NHL ranging in age from 5 to 76 years, with the mean age of 42 of the types were separated into three major prognostic groupings as follows: 1. low (41 of 249 cases, small lymphocytic 27 cases, lymphoplasmacytoid 2 cases, follicular cleaved 7 cases, follicular cleaved and noncleaved 5 cases); 2. intermediate (58 of 249 cases, diffuse cleaved 28 cases, diffuse cleaved and noncleaved 27 cases, follicular noncleaved 3 cases); and 3. high grade malignancy (150 of 249 cases, diffuse noncleaved 49 cases, lymphoblastic 41 cases, immunoblastic 13 cases, polymorphic 39 cases, clear cell 2 cases, histiocytic 6 cases). Each group was significantly different from the others (P less than 0.05). The prognosis of patients with angioimmunoblastic lymphadenopathy like T-cell lymphoma (9 of 249 cases) was not more significant (P greater than 0.05) than that of patients with other polymorphic lymphoma (30 of 249 cases). The results showed this Chengdu classification of NHL is good for practice and usage in clinical evaluation and routine surgical pathology.
Keywords:
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号